Your browser doesn't support javascript.
loading
Correction to: Fibroblast growth factor receptor 3 alterations and response to immune checkpoint inhibition in metastatic urothelial cancer: a real world experience.
Rose, Tracy L; Weir, William H; Mayhew, Gregory M; Shibata, Yoichiro; Eulitt, Patrick; Uronis, Joshua M; Zhou, Mi; Nielsen, Matthew; Smith, Angela B; Woods, Michael; Hayward, Michele C; Salazar, Ashley H; Milowsky, Matthew I; Wobker, Sara E; McGinty, Katrina; Millburn, Michael V; Eisner, Joel R; Kim, William Y.
Afiliación
  • Rose TL; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Weir WH; Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Mayhew GM; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Shibata Y; GeneCentric Therapeutics, Inc., Durham, NC, USA.
  • Eulitt P; GeneCentric Therapeutics, Inc., Durham, NC, USA.
  • Uronis JM; Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Zhou M; GeneCentric Therapeutics, Inc., Durham, NC, USA.
  • Nielsen M; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Smith AB; Department of Urology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Woods M; Department of Urology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Hayward MC; Department of Urology, Loyola University, Chicago, IL, USA.
  • Salazar AH; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Milowsky MI; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Wobker SE; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • McGinty K; Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Millburn MV; Department of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Eisner JR; Department of Radiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Kim WY; GeneCentric Therapeutics, Inc., Durham, NC, USA.
Br J Cancer ; 126(8): 1237, 2022 May.
Article en En | MEDLINE | ID: mdl-35277660
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Br J Cancer Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Br J Cancer Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos